Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Darinaparsin

EU orphan designation number: EU/3/11/850   
Active ingredient: Darinaparsin
Indication: Treatment of peripheral T-cell lymphoma (nodal, other extranodal and leukaemic/disseminated)
Sponsor: IDEA Innovative Drug European Associates Limited
19 Eastbourne Terrace, London W2 6LG, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/04/2011 Orphan designation EMA/OD/112/10 (2011)2837 of 15/04/2011
28/09/2016 Transfer of orphan designation EMA/OD/112/10/T/01 (2016) 6305 of 26/09/2016